Real-time enrollment status for this her2-negative breast cancer clinical trial
Current Status
Recruiting
Checked: October 11, 2026 at 12:04 AM UTC
| NCT Number | NCT07227831 |
| Recruiting Status | Recruiting |
| Condition | HER2-negative Breast Cancer |
| Phase | NA |
| Target Enrollment | 82 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Barbara Ann Karmanos Cancer Institute |
| Last Updated on CT.gov | August 26, 2026 (Aug 26, 2026) |
As of October 11, 2026: Clinical trial NCT07227831 is currently recruiting participants. This na study for her2-negative breast cancer is actively seeking new participants at 8 locations across the United States. The study is sponsored by Barbara Ann Karmanos Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227831 is actively recruiting participants as of October 11, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227831 was last updated Aug 26, 2026 (August 26, 2026). HelloStudys verifies this status automatically.